First Time Loading...

BELLUS Health Inc
TSX:BLU

Watchlist Manager
BELLUS Health Inc Logo
BELLUS Health Inc
TSX:BLU
Watchlist
Price: 19.48 CAD -0.1% Market Closed
Updated: May 2, 2024

BELLUS Health Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BELLUS Health Inc
Revenue Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
BELLUS Health Inc
TSX:BLU
Revenue
$15k
CAGR 3-Years
-21%
CAGR 5-Years
-35%
CAGR 10-Years
-40%
Zymeworks Inc
NYSE:ZYME
Revenue
$76m
CAGR 3-Years
25%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Revenue
$51.1m
CAGR 3-Years
700%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Revenue
$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Revenue
$175.5m
CAGR 3-Years
52%
CAGR 5-Years
223%
CAGR 10-Years
68%
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.6m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
-5%

See Also

What is BELLUS Health Inc's Revenue?
Revenue
15k USD

Based on the financial report for Mar 31, 2023, BELLUS Health Inc's Revenue amounts to 15k USD.

What is BELLUS Health Inc's Revenue growth rate?
Revenue CAGR 10Y
-40%

Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for BELLUS Health Inc have been -21% over the past three years , -35% over the past five years , and -40% over the past ten years .